Key result
Intravenous L-arginine decreased peak plasma ammonia and lactate during maximal exercise compared to placebo.
Why the study?
Does intravenous L-arginine supplementation reduce exercise-induced increases in plasma lactate and ammonia in healthy subjects?
RCT (n=8)
Double-blind
Does intravenous L-arginine supplementation reduce exercise-induced increases in plasma lactate and ammonia in healthy subjects?
Intravenous L-arginine supplementation reduces exercise-induced increases in plasma lactate and ammonia, potentially by enhancing the nitric oxide pathway.
Answers are grounded in this paper and cite their sources.
Reduces metabolic stress during maximal exercise in healthy subjects; confirms acute benefits of intravenous L-arginine in this RCT.
To investigate the effect of L-arginine supplementation (L-ARG) on physiological and metabolic changes during exercise, we determined in a double-blind study the cardiorespiratory (heart rate, oxygen consumption (VO(2)) and carbon dioxide production (VCO(2)) and the metabolic (lactate and ammonia) responses to maximal exercise after either an intravenous L-ARG hydrochloride salt or placebo load in 8 healthy subjects. Exercise-induced increases in heart rate, VO(2) and VCO(2) were not significantly different after L-ARG or placebo. By contrast, peak plasma ammonia and lactate were significantly decreased after L-ARG load (60.6 +/- 8.2 vs. 73.1 +/- 9.1 micro mol x l(-1), p < 0.01 and 7.1 +/- 0.7 vs. 8.2 +/- 1.1 mmol x l(-1), p < 0.01, for ammonia and lactate, respectively). Plasma L-citrulline increased significantly during exercise only after L-ARG load, despite a concomitant decrease in plasma L-ARG. Furthermore, a significant inverse relationship was observed between changes in lactate and L-citrulline concentrations after L-ARG load (r = -0.84, p = 0.009). These results demonstrate that intravenous L-ARG reduces significantly exercise-induced increase in plasma lactate and ammonia. Taken together, the specific L-citrulline increase and the inverse relationship observed between L-citrulline and plasma lactate after L-ARG might support that L-ARG supplementation enhances the L-arginine-nitric oxide (NO) pathway during exercise.
No takes yet. Share an insight, caveat, or question.
Schaefer et al. (2002) conducted an RCT in Healthy (n=8). Intravenous L-arginine hydrochloride salt vs. Placebo was evaluated on Peak plasma ammonia (p=<0.01). Intravenous L-arginine decreased peak plasma ammonia and lactate during maximal exercise compared to placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: